Status:
TERMINATED
A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Vitreoretinal Traction Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Plasmin is expected to create a posterior vitreous detachment (PVD) when injected directly into the eye. The pharmacological creation of a PVD may be beneficial in helping to treat a variety of condit...
Eligibility Criteria
Inclusion
- Patients who are in need of a vitrectomy.
Exclusion
- A PVD in the study eye as assessed by the investigator using ophthalmic and alternative examination techniques.
- A history of vitrectomy in the study eye.
- A media opacity that precludes quality examination of the vitreous and fundus in the study eye.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT00347646
Start Date
September 1 2006
End Date
June 1 2007
Last Update
June 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Cleveland
Cleveland, Ohio, United States, 44106